drug prices

csrxp

FDA Approves New Cholesterol-Lowering Treatments

“The approval of Repatha is another example of a breakthrough medication with a too high price tag. With several game-changing medications in the pipeline, we need to address the underlying issue of how these prices are set from the start before they hit the market.”

Read more
The Hill

The Hill: FDA approves cholesterol drug with $15,000 yearly price tag

“Breakthrough treatments such as Praluent hold tremendous medical promise for certain patients, but its price tag makes us question how long the health system can sustain these costs for patients managing chronic conditions over several years,” John Rother, president of the National Coalition on Health Care, said in a statement.

Read more
csrxp

PRESS STATEMENT: FDA Approves Praluent, New Cholesterol-Lowering Treatment

“Breakthrough treatments such as Praluent hold tremendous medical promise for certain patients, but it’s price tag makes us question how long the health system can sustain these costs for patients managing chronic conditions over several years.”

Read more
washingtonpost

Cancer experts call for curbs on rising drug prices

In recent years, increasingly specialized medications and an aging population that takes more drugs have substantially boosted the price of treatments for cancer, hepatitis C, cystic fibrosis and other diseases.

Read more